Radiolabelled IV and Oral Metabolism Study of F901318

Summary

Open label radiolabelled metabolism study of intravenous and oral solution forms of F901318. Five healthy male subjects will receive IV and five will receive an oral solution. Blood, urine and faeces will be collected over a period adequate to obtain 90% recovery of parent compound and to determine the metabolic profile of both IV and oral forms.

Timeline

Start

2019-05

Primary completion

2019-07

Completion

2019-07

Drugs

Indications